John Busch Patient

John was diagnosed with multiple myeloma more than 16 years ago through a routine blood test revealing elevated proteins.  He is cycling as a “small token of my gratitude,” he said, for all that MMRF has done for myeloma patients, researchers and medical providers. Since 2006, he has endured numerous types of treatments, buoyed by incredible medical advancements, dedicated medical providers, family and friends, and spiritual inspiration, he adds. Busch is also riding “for all the folks who can’t participate,” he said. “It is a blessing to be able and fit enough to do something extraordinary like this ride.”

Sorry, there are no posts from this member.
The Multiple Myeloma Research Foundation (MMRF) is the largest nonprofit in the world solely focused on accelerating a cure for each and every multiple myeloma patient. We drive the development and delivery of next-generation therapies, leverage data to identify optimal and more personalized treatment approaches, and empower myeloma patients and the broader community with information and resources to extend their lives. Central to our mission is our commitment to advancing health equity so that all myeloma patients can benefit from the scientific and clinical advances we pursue. Since our inception, the MMRF has committed over $500 million for research, opened nearly 100 clinical trials, and helped bring 15+ FDA-approved therapies to market, which have tripled the life expectancy of myeloma patients. To learn more, visit

Learn More

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity.

Learn more About Johnson & Johnson inovative medicine Learn more About Johnson & Johnson Follow us on @JanssenUS And @JNJInnovMed